Biotech Stocks: Is ASCO Much Ado About Nothing?
In some past years, the data dump has sparked investor excitement and pushed biotech stocks higher — sometimes significantly — heading into the event. It’s already happening. Today, shares of Incyte (INCY) spiked 7% on better-than-expected data …
and more »